Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Director | February 14, 2026 | February 17, 2026 |
| CENTENE CORPCNC · Entity 3133 | President & COO | December 10, 2022 | December 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date February 14, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 54,258 |
Reported balance
After 2026-02-14 transaction · row 1
1 source rowRow 1 · 2026-02-14 · Grant · Acquired 18,916 · Balance 54,258 F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.
CENTENE CORP
Report date December 10, 2022 · Filed December 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 562,852.609 |
Reported balance
After 2022-12-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-12-10 · Tax withholding · Disposed 2,985 · Balance 562,852.609 F1: Shares withheld for taxes upon vesting of previously reported stock grant. F2: Ownership includes 325,127 shares of restricted stock subject to vesting requirements. F3: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program. |
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $81.85 · Expires 2031-12-15 | Direct | 13,449 |
Reported balance
Holding disclosure · report date 2022-12-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 13,449 F4: Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for taxes upon vesting of previously reported stock grant.
F2: Ownership includes 325,127 shares of restricted stock subject to vesting requirements.
F3: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program.
F4: Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Sharecare, Inc.
Report date October 22, 2024 · Filed October 25, 2024
Section 16 reporting ended · disclosed 2024-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-10-22 transaction · row 1
1 source rowRow 1 · 2024-10-22 · Disposition to issuer · Disposed 2,290,308 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-10-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-22 · Disposition to issuer · Disposed 7,500,001 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2026 Filed Feb 17, 2026 17:30 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 18,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-055179 · ownership.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,258 F1 · shares: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:45 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 28,261 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032974 · ownership.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,342 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| November 01, 2024 Filed Nov 14, 2024 21:19 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 7,081 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-127368 · ownership.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,081 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| October 22, 2024 Filed Oct 25, 2024 06:06 UTC | Sharecare, Inc. SHCR · Entity 86549 | Disposition to issuerRestricted Stock Units · Derivative | 7,500,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043721 · wk-form4_1729850796.xml · derivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500,001 shares Expires not disclosed F2 · derivative.exercise_price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration. F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into (x) a Contingent Cash Award in an amount in cash equal to (A) 70% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration and (y) a Contingent Unit Award having a capital value at the Effective Time equal to (A) 30% of the number of shares of Company Common Stock subject to such Company RSU Award multiplied by (B) the Merger Consideration. Read SEC document |
| October 22, 2024 Filed Oct 25, 2024 06:06 UTC | Sharecare, Inc. SHCR · Entity 86549 | Disposition to issuerCommon Stock | 2,290,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-043721 · wk-form4_1729850796.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:33 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 833,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-042463 · wk-form4_1728347591.xml · derivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500,001 Underlying: Common Stock · 833,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on October 3, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.exercise_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on October 3, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.expiration_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on October 3, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:33 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 833,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-042463 · wk-form4_1728347591.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,290,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on October 3, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 21:32 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 833,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-033602 · wk-form4_1722389533.xml · derivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333,334 Underlying: Common Stock · 833,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on July 26, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.exercise_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on July 26, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.expiration_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on July 26, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 21:32 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 833,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-033602 · wk-form4_1722389533.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,456,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on July 26, 2024. RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:15 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 131,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027950 · wk-form4_1718241309.xml · derivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,034 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Filed to report vesting and settlement of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 17, 2023, Reporting Person was granted 131,034 RSUs, which vest on the earlier of (i) the 2024 annual meeting of the Company's stockholders and (ii) May 17, 2024, subject to Reporting Person's continued service as a director of the Company. Accordingly, the RSUs vested on May 17, 2024 and were settled on June 10, 2024. F2 · derivative.expiration_date: On May 17, 2023, Reporting Person was granted 131,034 RSUs, which vest on the earlier of (i) the 2024 annual meeting of the Company's stockholders and (ii) May 17, 2024, subject to Reporting Person's continued service as a director of the Company. Accordingly, the RSUs vested on May 17, 2024 and were settled on June 10, 2024. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:15 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 131,034 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-027950 · wk-form4_1718241309.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 623,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Filed to report vesting and settlement of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:35 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 833,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-24-000084 · wk-form4_1712280914.xml · derivative · entry 3 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,166,667 Underlying: Common Stock · 833,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on April 2, 2024 (397,793 of which were withheld by the issuer to cover the required withholding taxes of RSUs). RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.exercise_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on April 2, 2024 (397,793 of which were withheld by the issuer to cover the required withholding taxes of RSUs). RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. F1 · derivative.expiration_date: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on April 2, 2024 (397,793 of which were withheld by the issuer to cover the required withholding taxes of RSUs). RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:35 UTC | Sharecare, Inc. SHCR · Entity 86549 | Tax withholdingCommon Stock | 397,793 | $0.55 | $218,786.15 |
DisclosureSEC source: 0001816233-24-000084 · wk-form4_1712280914.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,608 Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:35 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 833,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001816233-24-000084 · wk-form4_1712280914.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 890,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 2, 2024, Reporting Person was granted 10,000,000 Restricted Stock Units ("RSUs"), vesting in twelve equal installments quarterly from 2024 - 2026. Accordingly, 833,333 RSUs vested and were settled on April 2, 2024 (397,793 of which were withheld by the issuer to cover the required withholding taxes of RSUs). RSUs convert into common stock ("Common Stock") of Sharecare, Inc. (the "Company") on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 19:20 UTC | Sharecare, Inc. SHCR · Entity 86549 | Disposition to issuerCommon Stock | 901 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-24-000037 · wk-form4_1708474806.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,068 F1 · shares: Represents forfeited restricted stock units ("RSUs") in lieu of director cash compensation (as elected by Reporting Person and previously reported) that decreased as a result of the Sharecare, Inc. Board of Director's changed committee composition in November 2023, which accordingly lowered Reporting Person's director compensation for the remainder of 2023. The final (decreased) tranche of RSUs vested on February 15, 2024. F1 · price: Represents forfeited restricted stock units ("RSUs") in lieu of director cash compensation (as elected by Reporting Person and previously reported) that decreased as a result of the Sharecare, Inc. Board of Director's changed committee composition in November 2023, which accordingly lowered Reporting Person's director compensation for the remainder of 2023. The final (decreased) tranche of RSUs vested on February 15, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 19:57 UTC | Sharecare, Inc. SHCR · Entity 86549 | GrantRestricted Stock Units · Derivative | 10,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-24-000002 · wk-form4_1704416262.xml · derivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000,000 Underlying: Common Stock · 10,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. F2 · derivative.exercise_date: One-twelfth (1/12) of the RSUs will vest quarterly (every consecutive three months) starting 4/2/24 and ending 1/2/27, provided that Reporting Person is still employed by the Company or an affiliate thereof through the applicable vesting dates. F2 · derivative.expiration_date: One-twelfth (1/12) of the RSUs will vest quarterly (every consecutive three months) starting 4/2/24 and ending 1/2/27, provided that Reporting Person is still employed by the Company or an affiliate thereof through the applicable vesting dates. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 18:13 UTC | Sharecare, Inc. SHCR · Entity 86549 | GrantCommon Stock | 28,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-23-000140 · wk-form4_1688595215.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,969 F1 · shares: Represents the grant of restricted stock units ("RSUs") in lieu of director cash compensation (as elected by reporting person). Such RSUs vest one-third (1/3) each on August 15, 2023, November 15, 2023, and February 15, 2024, respectively, provided that reporting person is still serving as a director of the Company through the applicable vesting date. Read SEC document |
| June 06, 2023 Filed Jul 5, 2023 18:10 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 29,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-23-000138 · wk-form4_1688595033.xml · derivative · entry 2 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,802 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Filed to report vesting of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 15, 2023, the Reporting Person was granted 29,802 RSUs, which vest on the earlier of (i) the 2023 annual meeting of the Company's stockholders and (ii) February 15, 2024, subject to the Reporting Person's continued service as a director of the Company. The 2023 annual meeting of the Company's stockholders was held on June 6, 2023. F2 · derivative.expiration_date: On February 15, 2023, the Reporting Person was granted 29,802 RSUs, which vest on the earlier of (i) the 2023 annual meeting of the Company's stockholders and (ii) February 15, 2024, subject to the Reporting Person's continued service as a director of the Company. The 2023 annual meeting of the Company's stockholders was held on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jul 5, 2023 18:10 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 29,802 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001816233-23-000138 · wk-form4_1688595033.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Filed to report vesting of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis. Read SEC document |
| May 17, 2023 Filed May 19, 2023 19:54 UTC | Sharecare, Inc. SHCR · Entity 86549 | GrantRestricted Stock Units · Derivative | 131,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-23-000093 · wf-form4_168454047051287.xml · derivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,034 Underlying: Common Stock · 131,034 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of (i) the 2024 annual meeting of the Company's stockholders and (ii) May 17, 2024, subject to the Reporting Person's continued service as a director of the Company. F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of (i) the 2024 annual meeting of the Company's stockholders and (ii) May 17, 2024, subject to the Reporting Person's continued service as a director of the Company. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 16:56 UTC | Sharecare, Inc. SHCR · Entity 86549 | GrantRestricted Stock Units · Derivative | 29,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001816233-23-000037 · wf-form4_167667097958224.xml · derivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,802 Underlying: Common Stock · 29,802 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of (i) the next annual meeting of the Company's stockholders following the grant date and (ii) February 15, 2024, subject to the Reporting Person's continued service as a director of the Company. F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of (i) the next annual meeting of the Company's stockholders following the grant date and (ii) February 15, 2024, subject to the Reporting Person's continued service as a director of the Company. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:57 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,985 | $86.25 | $257,456.25 |
DisclosureSEC source: 0001071739-22-000385 · wf-form4_167097583228351.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,852.609 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 325,127 shares of restricted stock subject to vesting requirements. F3 · balance_after: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 22:42 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,010 | $81.87 | $164,558.70 |
DisclosureSEC source: 0001071739-22-000247 · wf-form4_165636972451778.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,772.686 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 331,794 shares of restricted stock subject to vesting requirements. Read SEC document |
| April 26, 2022 Filed Apr 29, 2022 01:34 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 30,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000208 · wf-form4_165119581201975.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,782.686 F1 · balance_after: Ownership includes this award of 30,638 restricted stock units. 18,383 units are performance stock units and vest on December 31, 2024. The number of performance stock units that vest will be based on the achievement of performance conditions for the three-year performance period ending December 31, 2024. The remaining 12,255 units will vest on December 31, 2024. In addition, ownership includes 305,656 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:32 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,977 | $82.46 | $245,483.42 |
DisclosureSEC source: 0001071739-22-000118 · wf-form4_164850673664304.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,113.429 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 305,656 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 22, 2021 Filed Dec 24, 2021 00:51 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 3,730 | $82.99 | $309,552.70 |
DisclosureSEC source: 0001071739-21-000288 · wf-form4_164030706836378.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,058.492 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 312,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:50 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock Option (right to buy) · Derivative | 13,449 | $0.00 Strike: $81.85 | $0.00 |
DisclosureSEC source: 0001071739-21-000276 · wf-form4_163978499945540.xml · derivative · entry 4 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,449 Underlying: Common Stock · 13,449 shares Expires 2031-12-15 F4 · derivative.exercise_date: Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:50 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 31,155 | $81.85 | $2,550,036.75 |
DisclosureSEC source: 0001071739-21-000276 · wf-form4_163978499945540.xml · nonDerivative · entry 3 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,788.492 F3 · balance_after: Ownership includes this award of 31,155 restricted stock units. 16,494 units are performance stock units. The number of performance stock units vesting at the end of the three-year period is predicated on meeting three-year performance conditions. The remaining 14,661 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 289,501 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:50 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 26,243 | $81.85 | $2,147,989.55 |
DisclosureSEC source: 0001071739-21-000276 · wf-form4_163978499945540.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,633.492 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:50 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 14,640 | $66.23 | $969,607.20 |
DisclosureSEC source: 0001071739-21-000276 · wf-form4_163978499945540.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,876.492 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from December 2018 with a three-year performance period. Refer to Form 3 filed on February 12, 2021. 30,000 shares were reported based on achievement of target level of performance. Read SEC document |
| December 11, 2021 Filed Dec 15, 2021 01:37 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,984 | $78.45 | $234,094.80 |
DisclosureSEC source: 0001071739-21-000260 · wf-form4_163953223815550.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,236.492 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 333,501 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 01:37 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,984 | $74.87 | $223,412.08 |
DisclosureSEC source: 0001071739-21-000260 · wf-form4_163953223815550.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,220.492 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 00:03 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 3,923 | $70.64 | $277,120.72 |
DisclosureSEC source: 0001071739-21-000237 · wf-form4_163581137941824.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,204.492 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 5, 2021. F2 · balance_after: Ownership includes 346,836 shares of restricted stock units subject to vesting requirements. Read SEC document |
| October 28, 2021 Filed Nov 2, 2021 00:03 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 77 | $70.17 | $5,403.09 |
DisclosureSEC source: 0001071739-21-000237 · wf-form4_163581137941824.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,127.492 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 5, 2021. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 23:14 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 110,000 | $64.37 | $7,080,700.00 |
DisclosureSEC source: 0001071739-21-000196 · wf-form4_163122925110821.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,162.259 F1 · balance_after: Ownership includes this award of 110,000 restricted stock units, which will vest in full on the third anniversary of the date of grant. In addition, ownership includes 236,836 shares of restricted stock units subject to vesting requirements. Read SEC document |
| August 02, 2021 Filed Sep 9, 2021 23:14 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-21-000196 · wf-form4_163122925110821.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,162.259 Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 22:43 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 4,000 | $70.00 | $280,000.00 |
DisclosureSEC source: 0001071739-21-000187 · wf-form4_162794417419025.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · EVP, Pres. HP, Products & Intl 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,662.259 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 5, 2021. F2 · balance_after: Ownership includes 236,836 shares of restricted stock units subject to vesting requirements. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:11 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 13,500 | $72.20 | $974,700.00 |
DisclosureSEC source: 0001071739-21-000158 · wf-form4_162465185638544.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · EVP, Pres. HP, Products & Intl 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,626.176 F1 · balance_after: Ownership includes this award of 13,500 restricted stock units which will vest in three equal installments on the anniversary of the grant date. In addition, ownership includes 223,336 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:46 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 7,682 | $65.00 | $499,330.00 |
DisclosureSEC source: 0001071739-21-000129 · wf-form4_162033757339792.xml · nonDerivative · entry 2 LAYTON BRENT D · CIK 0001731041 · EVP, Chief BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,126.176 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 5, 2021. F2 · balance_after: Ownership includes 223,336 shares of restricted stock subject to vesting requirements. Read SEC document |
| April 15, 2021 Filed May 6, 2021 21:46 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 795 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-21-000129 · wf-form4_162033757339792.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · EVP, Chief BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,808.176 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 22:17 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,984 | $64.06 | $191,155.04 |
DisclosureSEC source: 0001071739-21-000066 · wf-form4_161671063513914.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · EVP, Chief BD Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,562 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 223,336 shares of restricted stock subject to vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.